Document:

ex10-2.htm

    Exhibit
      10.2

    
 

    
      
        ASSIGNMENT
          AGREEMENT

      

       

      IN
        THIS
        ASSIGNMENT AGREEMENT (this “Agreement”), made and entered into as of the 24th
        day of April, 2007 (the “Effective Date”), TERABEAM, INC., a Delaware
        corporation having offices at 2115 O’Nel Drive, San Jose, CA and its Subsidiary
        Proxim Wireless Corporation, a Delaware corporation having offices at 2115
        O’Nel
        Drive, San Jose, CA (collectively “TERABEAM”), and SPH AMERICA, LLC, a Virginia
        limited liability company having offices at 11289 Stones Throw Dr., Reston,
        VA
        (“SPH”), agree as follows:

       

      
        	
                 

              	
                1.

              	
                TERABEAM
                  desires to transfer all of its right, title, and interest in and
                  to the
                  U.S. patents and U.S. patnt application listed in Attachment A
                  (collectively, the “Patents”).

              

      

       

      
        	
                 

              	
                2.

              	
                Subject
                  to completion of due diligence as provided in Section 4 below,
                  SPH desires
                  to acquire and TERABEAM is willing to assign to SPH all of TERABEAM’s
                  right, title, and interest in and to the Patents, and any inventions
                  disclosed and claimed therein, along in each case with any U.S.
                  reissue or
                  reexamination of any of the Patents, and with any foreign patent
                  or
                  application which claims priorty to any of the Patents (including
                  foreign
                  divisional, continuation, continuation-in-part, reissue, reexamination,
                  inventor certificate, utility model, or any other intellectual
                  property or
                  other applications), and all foreign patents, inventor certificates,
                  utility models, or other intellectual property rights that may
                  be granted
                  thereon, all rights to claim priority on the basis of any such
                  patent or
                  application, and any and all reissues, reexaminations, and extensions
                  of
                  any of the foregoing (collectively, the “Assigned
                  Patents”).

              

      

       

      
        	
                 

              	
                3.

              	
                Pursuant
                  to Section 7 below, and subject to completion of due diligence
                  as provided
                  in Section 4 below, TERABEAM shall transfer, grant, convey, assign,
                  and
                  relinquish exclusively to SPH all of TERABEAM’s right, title, and interest
                  in and to the Assigned Patents.  TERABEAM further shall transfer
                  and assign to SPH all causes of action, rights, and remedies arising
                  under
                  the Assigned Patents prior to, on, or after the Effective Date
                  of this
                  Agreement, including the right to sue to enforce the Assigned Patents
                  and
                  receive damages, including past, present, and future damages, for
                  infringement thereof.

              

      

       

      
        	
                 

              	
                4.

              	
                In
                  consideration of TERABEAM’s assignment as set forth herein, and subject to
                  due diligence on previously granted licenses to the Assigned Patents
                  to be
                  completed by May 30, 2007, (a) on or before June 30, 2007, SPH
                  will pay to
                  TERABEAM the sum of TWO MILLION, FIVE HUNDRED THOUSAND dollars
                  ($2,500,000) by wire transfer of immediately available funds pursuant
                  to
                  wire transfer instructions provided by TERABEAM within fifteen
                  (15) days
                  of the Effective Date, and (b) SPH hereby grants to TERABEAM the
                  rights
                  described in Attachment D.  In the event that due diligence on
                  previously granted licenses to the Assigned Patents (which shall
                  be
                  completed by May 30, 2007) reveals a reasonable basis for SPH to
                  no longer
                  desire to purchase the Assigned Patents and SPH so notifies TERABEAM
                  in
                  writing on or before May 30, 2007, the Parties’ obligations under this
                  Agreement shall be void and withdrawn, including, for the avoidance
                  of
                  doubt, TERABEAM’s obligation to assign
                  the

              

      

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      Assigned
        Patents to SPH and SPH’s obligation to make any monetary payments to
        TERABEAM.  In the event that SPH does not provide notice to TERABEAM
        that it does not want to proceed with the purchase on or before May 31, 2007,
        this due diligence contingency shall be deemed satisfactorily fulfilled and
        no
        longer constitute a condition to either party’s performance of its obligations
        under this Agreement.  The parties shall bear their own costs, fees,
        and expenses in completing due diligence contemplated by this
        paragraph.

       

      
        	
                 

              	
                5.

              	
                TERABEAM
                  and SPH acknowledge that this Agreement will be filed with the
                  Securities
                  and Exchange Commission, and thus made publicly
                  available.  TERABEAM shall file the attachments to this
                  Agreement only to the extent required in the opinion of its counsel
                  and,
                  if filing is required, TERABEAM shall use its reasonable efforts
                  to have
                  as much of the attachments redacted and treated
                  confidentially.  Subject to the foregoing, the parties agree
                  that the provisions of the Confidentiality Agreement, dated as
                  of April
                  24, 2007, apply to the negotiation of and transactions contemplated
                  by
                  this Agreement.

              

      

       

      
        	
                 

              	
                6.

              	
                In
                  the event that, in any action involving any of the Assigned Patents,
                  there
                  is any allegation of invalidity, unenforceability, or noninfringement
                  of
                  any of the Assigned Patents, SPH and TERABEAM agree to cooperate
                  reasonably with each other in any such action at SPH’s
                  expense.

              

      

       

      
        	
                 

              	
                7.

              	
                TERABEAM
                  will execute and deliver to SPH the Assignment in Attachment B
                  hereto with
                  respect to each of the Assigned Patents, in each case before June
                  10, 2007
                  (to an escrow agent reasonably acceptable to both TERABEAM and
                  SPH for
                  delivery to SPH after TERABEAM receives the consideration contemplated
                  in
                  Section 4 above) to evidence the transfer of TERABEAM’s rights in all the
                  Assigned Patents from TERABEAM to SPH to the fullest extent possible.
                  TERABEAM further agrees to provide testimony in connection with
                  any
                  proceeding affecting the right, title, interest, or benefit of
                  SPH in and
                  to the Assigned Patents, to execute and deliver all other papers
                  that may
                  be necessary or desirable to transfer TERABEAM’s right, title, and
                  interest to the Assigned Patents in SPH, its successors and assigns,
                  to
                  execute all divisional, continuation, reissue, and reexamination
                  applications and assignments, to make all rightful oaths, and to
                  perform
                  any other acts deemed reasonably necessary to carry out the intent
                  of this
                  Agreement, in each case at SPH’s expense except to the extent any such
                  costs, expenses, fees, or damages arise from the misconduct or
                  negligence
                  of TERABEAM or its current employees, agents, or representatives
                  and
                  except that TERABEAM’s efforts with respect to former employees shall be
                  limited to reasonable efforts.

              

      

       

      
        	
                 

              	
                8.

              	
                In
                  furtherance of this Agreement, TERABEAM hereby acknowledges that,
                  from
                  June 30, 2007 forward but subject to the other terms of this Agreement,
                  SPH has succeeded to all of TERABEAM’s right, title, and standing to
                  receive all rights and benefits pertaining to the Assigned Patents,
                  institute and prosecute all suits and ­proceedings, and take all
                  actions that SPH, in its sole discretion, may deem necessary or
                  proper to
                  collect, assert, or enforce any claim, right, or title of any kind
                  under
                  any and all of the Assigned Patents, whether arising before, on,
                  or after
                  the Effective Date, to defend and compromise any and all such
                  actions,

              

      

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      claims,
        suits, or proceedings relating to such transferred and assigned rights, title,
        interest, and benefits, and to do all other such acts and things in relation
        thereto as SPH, in its sole discretion, deems advisable.

       

      
        	
                 

              	
                9.

              	
                TERABEAM
                  represents and warrants that no consents of any other parties are
                  necessary under any agreements concerning any of the Assigned Patents
                  in
                  order for the transfer and assignment of any of the Assigned Patents
                  under
                  this Agreement to be legally effective, that no obligation of TERABEAM
                  will be breached by the assignments made herein, and that TERABEAM
                  shall
                  not execute any agreement with any third party in conflict
                  herewith.

              

      

       

      
        	
              	
                10.

              	
                TERABEAM
                  represents and warrants that, to the best of TERABEAM’s knowledge, upon
                  consummation of this Agreement and execution and delivery of Assignments
                  substantially in the form of Attachment B, SPH shall have good
                  and
                  marketable title to the Assigned Patents, free and clear of any
                  and all
                  liens, mortgages, encumbrances, pledges, security interests, licenses,
                  or
                  charges of any nature whatsoever except for matters listed in Attachment
                  C
                  (as may be supplemented by TERABEAM at any time on or before May
                  20,
                  2007).  SPH acknowledges that TERABEAM acquired the Assigned
                  Patents from previous owners and/or assignees, including entities
                  in
                  bankruptcy, and therefore matters may have occurred in the past
                  as to
                  which the current management of TERABEAM never had any
                  knowledge.

              

      

       

      THE
        WARRANTIES SPECIFICALLY SET FORTH IN SECTIONS 9 AND 10 ABOVE ARE THE ONLY
        WARRANTIES GIVEN BY TERABEAM WITH RESPECT TO THE ASSIGNED PATENTS AND ARE
        GIVEN
        IN LIEU OF ANY AND ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY,
        OR
        ARISING BY CUSTOM, TRADE USAGE, OR COURSE OF DEALING, INCLUDING WITHOUT
        LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
        PURPOSE, AND TERABEAM HEREBY DISCLAIMS ANY AND ALL OTHER WARRANTIES TO THE
        MAXIMUM EXTENT PERMITTED BY LAW.  Without limiting the generality of
        the foregoing sentence, TERABEAM makes no warranty or representation, either
        expressed or implied, as to the validity of any of the Assigned
        Patents.

       

      
        	
              	
                11.

              	
                In
                  the case of Force Majeure preventing or hindering either party
                  from
                  performing its obligations under this Agreement, such Force Majeure
                  shall
                  not constitute a breach or default under this Agreement provided
                  that: (i)
                  the party prevented or hindered from performing (the “Affected Party”)
                  shall give written notice to the other party (the “Non-Affected Party”),
                  as soon as practically possible, containing reasonable particulars
                  of the
                  Force Majeure in question and the effect of such Force Majeure
                  as it
                  relates to the obligations of the Affected Party; and (ii) the
                  Affected
                  Party works diligently to correct the reason for such delay, excuses
                  performance by the Non-Affected Party during the period of such
                  delay, and
                  reimburses the Non-Affected Party for any losses incurred by the
                  Non-Affected Party by reason of such
                  delay.

              

      

       

      
        	
              	
                12.

              	
                This
                  Agreement shall inure to the benefit of, and be binding on, the
                  parties
                  hereto together with their respective legal representatives, and
                  successors and assigns.

              

      

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      
        	
              	
                13.

              	
                This
                  Agreement shall be governed by and construed in accordance with
                  the laws
                  of the State of New York and of the United
                  States.

              

      

       

      
        	
              	
                14.

              	
                This
                  Agreement merges and supersedes all prior and contemporaneous agreements,
                  assurances, representations, and communications between or among
                  the
                  parties hereto concerning the matters set forth
                  herein.

              

      

       

      
        	
              	
                15.

              	
                SPH
                  hereby disclaims any and all warranties whatsoever in connection
                  with this
                  Agreement and any goods, services, and information provided hereunder,
                  whether express or implied.

              

      

       

      
        	
              	
                16.

              	
                The
                  waiver by either party of a breach or default of any of the provisions
                  of
                  the Agreement by the other party shall not be construed as a waiver
                  of any
                  succeeding breach of the same or any other provisions, nor shall
                  any delay
                  or omission on the part of either party to exercise or avail itself
                  of any
                  right, power or privilege that it has or may have hereunder, operate
                  as a
                  waiver of any breach or default by the other
                  party.

              

      

       

      
        	
              	
                17.

              	
                If
                  any provision of the Agreement shall be held by a court of competent
                  jurisdiction to be illegal, invalid or unenforceable, that provision
                  shall
                  be limited or eliminated to the minimum extent necessary so that
                  the
                  Agreement shall otherwise remain in full force and effect and
                  enforceable.

              

      

       

      
        	
              	
                18.

              	
                All
                  notices, requests, demands, consents, approvals, designations and
                  other
                  communications called for or contemplated by this Agreement shall
                  be in
                  writing and shall be deemed given to SPH or TERABEAM (i) when delivered
                  to
                  such party by hand or by overnight courier or delivery service,
                  or (ii)
                  three business days after being sent to such party by registered
                  or
                  certified mail (return receipt requested, postage prepaid), in
                  each case
                  at the address(es) for such party set forth above (or at such other
                  address as such party may designate by notice in the manner
                  aforesaid).

              

      

       

      IN
        WITNESS WHEREOF, the parties hereto have executed this Agreement under seal
        the
        day and year first above written.

      

      
        	
                TERABEAM,
                  INC.

              	
                SPH
                  AMERICA, LLC

              
	 	 
	
                By:  /s/  Robert
                  E. Fitzgerald

              	
                By:  /s/  Choongsoo
                  Park

              
	
                Date:  4/24/07

              	
                Date:  4/24/07

              
	 	 
	
                PROXIM
                  WIRELESS CORPORATION

              	 
	 	 
	
                By:  /s/
                  Robert E. Fitzgerald

              	 
	
                Date:  4/24/07Exhibit 10.1 Consent

    
      

    

    Exhibit
      10.1

    Consent
      of Independent Registered Public Accounting Firm

     

    We
      consent to the incorporation by reference in the Registration Statements on
      Form
      S-8 (Registration No. 333-12586, 333-13786, 333-14142, 333-83914, 333-104070,
      333-121229 and 333-138717) of Alvarion Ltd. of our report dated March 29, 2007,
      with respect to the consolidated financial statements of Alvarion Ltd. included
      in this annual report on Form 20-F for year ended December 31,
      2006.

    

    
      	 	
              /s/
                KOST, FORER GABBAY &
                KASIERER

            
	
              Tel-Aviv,
                Israel

            	
              A
                Member of Ernst & Young Global

            
	 	 
	 	 
	
              26
                April, 2007

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}]]